Search

Search Results
Results 7711 - 7720 of 8493 for Skin Cancer
  • Zypine and Zypine ODT
    Drug - 28 Nov 2025
    Consumer Medicine Information (CMI) about Zypine and Zypine ODT intended for persons living in Australia.
  • Exploring the combined antiproliferative effects of artesunate and resveratrol in Ishikawa endometrial cancer cells
    Health - 27 Nov 2025
    Study finds enhanced antiproliferative activity in Ishikawa cells using combined artesunate and resveratrol treatment.
  • M-M-R II
    Drug - 27 Nov 2025
    Consumer Medicine Information (CMI) about M-M-R II intended for persons living in Australia.
  • FluMist
    Drug - 27 Nov 2025
    Consumer Medicine Information (CMI) about FluMist intended for persons living in Australia.
  • Cimzia
    Drug - 24 Nov 2025
    Consumer Medicine Information (CMI) about Cimzia intended for persons living in Australia.
  • Enhertu
    Drug - 24 Nov 2025
    Consumer Medicine Information (CMI) about Enhertu intended for persons living in Australia.
  • Blenrep
    Drug - 21 Nov 2025
    Consumer Medicine Information (CMI) about Blenrep intended for persons living in Australia.
  • Tysabri
    Drug - 11 Nov 2025
    Consumer Medicine Information (CMI) about Tysabri intended for persons living in Australia.
  • Why Kiwifruit Is a Superfood: Health Benefits Supported by Research
    Health - 23 Oct 2025
    Discover how kiwifruit’s unique blend of fiber, vitamin C, and actinidin supports gut function, strengthens immunity, and enhances overall health through clinically backed evidence.
  • Pradaxa
    Drug - 14 Oct 2025
    Consumer Medicine Information (CMI) about Pradaxa intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback